Navigation Links
Homeless cells find temporary lodging -- and their demise

BOSTON, Mass. (Nov. 29, 2007)Sometimes healthy cells commit suicide. In the 1970s, scientists showed that a type of programmed cell death called apoptosis plays a key role in development, and the 2002 Nobel Prize in Physiology or Medicine recognized their work. As apoptotic cells degrade, they display standard characteristics, including irregular bulges in the membrane and nuclear fragmentation.

Now, Harvard Medical School researchers have uncovered a new type of death devoid of these features. In the Nov. 30 issue of Cell, they report a bizarre cell-in-cell invasion and death process, which they name entosis, after the Greek word for within.

We watched homeless cells, free of their normal attachments, bore into their neighbors and die inside compartments called vacuoles, says Michael Overholtzer, a postdoctoral researcher in Joan Brugges lab.

Were not sure if entosis evolved to play a particular role or if its simply an aberration of a normal process, adds Brugge, who is Chair of the Department of Cell Biology.

Overholtzer discovered entosis while working with human breast cells that normally form sheets of tissue. When these cells become detached from their protein-rich beds, they generally die through apoptosis. But Overholtzer noticed that they behave oddly long before displaying apoptotic features. In fact, many of these homeless cells actually nest inside their neighbors.

Further experimentation revealed that the cells actively invade neighboring cells. While some of the intruderswhich initially appear healthylater exit their hosts unharmed, most die inside vacuoles.

But Overholtzer didnt realize the implications of his initial observation until he crossed paths with Brigham and Womens Hospital pathologist Andrea Richardson. She informed him that the scientific literature is full of cell-in-cell references in the context of cancer.

Although these structures have been described by pathologists for decades, nobody knew how they formed, says Brugge.

Overholtzer conducted additional experiments with his non-cancerous cell line. In collaboration with Guillaume Normand of Associate Professor of Cell Biology Randall Kings lab, he tracked the cells over time and was shocked to see that some of them actively bored into their neighbors. Furthermore, the invaders appeared to be healthy.

The fate of the internalized cells was even more surprising. While most of them eventually died, some exited their hosts and swam off unharmed. Still others divided inside their vacuoles, producing daughter cellsand additional proof of the invaders viability. Overholtzer stained the suspended cells for a protein associated with apoptosis to confirm that it was not playing a role.

Pathologists have speculated for years that some internalized cells are alive and our data suggests they were right, says Overholtzer.

Next, he looked at other human cell lines. A variety of them displayed entosis when tested, including four of nine tumor lines. Cancerous MCF7 cells proved particularly prone to invasions with a whopping 30 percent of them housing neighbors. These hospitable hosts invited additional experiments.

After 24 hours, 12 percent of MCF7 cells displayed massive cellular and nuclear degradation lacking apoptotic hallmarks. All of these cells were nestled inside vacuoles, and stains implicated acidification in their death.

He still doesnt know which cell orders the killing, but it appears the houseguest forces its way into the host. The initial contacts between MCF7 cells resemble the junctions established during a normal epithelial process that occurs when cells press against each other to form dense sheets. In suspension, epithelial cells may hijack this process to push into neighboring cells or to pull the membrane of a neighboring cell around them.

The simplest explanation is that entosis is an aberration of normal epithelial processes, Overholtzer says. The invasion could occur when you get unequal contractile forces between two unanchored cells.

But he and Brugge havent ruled out other possibilities. Perhaps entosis represents a new type of programmed cell death that evolved for a particular purpose.

Its very difficult to know whether this is a cellular program with a normal role in development, says Brugge.

Regardless of its origins, entosis shows up in the clinic. Overholtzer collaborated with Edmund Cibas at Brigham and Womens Hospital and Stuart Schnitt at Beth Israel Deaconess Medical Center to obtain fluid exudates (derived from the circulatory system) and primary tumor tissue from breast cancer patients. Seven of eight exudates and 11 of 20 primary breast carcinomas displayed some cell internalization.

The next step is to determine if entosis helps or hurts cancer cells.

Our first instinct is that entosis inhibits tumor progression by killing homeless cancer cells before they colonize distant sites, and were working on ways to model this, says Overholtzer. One could also imagine that entosis promotes tumor progression by providing nutrients for some cells from their neighbors, but we do not yet have evidence for this.


Contact: Alyssa Kneller
Harvard Medical School

Related medicine news :

1. $8,000 Winning Bids at Governors Livestock Auction to Benefit College-Bound Youth and Homeless
2. United Way of Greater Los Angeles Kicks Off Initiative to Prevent and End Homelessness With HomeWalk 2007
3. The Jericho Project Announces Rehabilitation Residence for Homeless and Low-Income Veterans
4. Homeless Vets - VA Sets the Record Straight
5. New Gallup Survey Finds Half of Los Angeles Area Residents Have Taken in a Near-Homeless Person, One-Third Fear Homelessness Themselves
6. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
7. Brain cells work differently than previously thought
8. Embryonic Stem Cells Repair Human Heart
9. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
10. Circulating fats kill transplanted pancreas cells, study shows
11. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... for mental health and wellness consultation, has collaborated with Women’s Web – ... their reader’s queries on topics on mental and emotional well-being relationship, life ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... where preparing the perfect dish and pleasing the palates of attendees is of ... bringing a dish to a seasonal get-together, give these recipes a try this ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an article published November ... more widely heralded as a breakthrough for performing hernia repairs. The article explains that ... surgery is that it can greatly reduce the pain that a patient might otherwise ...
(Date:11/25/2015)... Raton, Florida (PRWEB) , ... November 25, 2015 ... ... diagnostic testing for physicians and athletic programs, launches new Wimbledon Athletics ... importance of testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: ... License Application (BLA) with the United States ... ABP 501, a biosimilar candidate to Humira ® ... biosimilar application submitted to the FDA and represents Amgen,s ... Sean E. Harper , M.D., executive vice president ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, ... optimizing treatment outcomes for patients suffering from chronic pain, ... for a Temporary Restraining Order (TRO) enjoining Express Scripts ... two companies. --> --> ... all of its legal options. --> ...
(Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
Breaking Medicine Technology: